Syrinx Pharmaceuticals is a GMP licensed facility with the latest technology and equipment to ensure the manufacture of high quality products. The manufacturing facility in Croydon, Victoria, Australia is Therapeutic Goods Administration (TGA) and Australian Pesticides and Veterinary Medicines Authority (APVMA) approved. Syrinx Pharmaceuticals is licensed to manufacture both oral and topical dosage forms (such as wafers, tablets, liquids and creams).
Syrinx Pharmaceuticals provides an integrated service supporting client projects from formulation development to packaging and release of finished product. Syrinx Pharmaceuticals can assist with every step of a client’s product lifecycle from formulation through to registration.
Syrinx Pharmaceuticals is a wholly-owned subsidiary of iX Biopharma Ltd, a specialty pharmaceutical company listed on the Singapore exchange. For more information on iX Biopharma, please visit www.ixbiopharma.com.